Approach to treatment of the febrile cancer patient with low-risk neutropenia

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

All cancer patients who develop fever during a period of neutropenia are not at high risk of developing serious infection. Following hospitalization for empiric broad spectrum antibiotic therapy, certain low-risk patients can be identified and safely be discharged 'early', prior to recovery of the absolute neutrophil count to 500 cells per mm3. The medical, psychological, and financial benefits of early hospital discharge are immense. Careful examination for serial increases in components of the peripheral blood count herald marrow recovery and help identify the low risk patient. It may also be possible to identify 'low-risk' neutropenic patients upon development of fever in order to explore alternative management strategies (for example, outpatient oral or intravenous antibiotics) rather than routine hospitalization.

Original languageEnglish (US)
Pages (from-to)919-935
Number of pages17
JournalHematology/Oncology Clinics of North America
Volume7
Issue number5
StatePublished - 1993

Fingerprint

Neutropenia
Fever
Neoplasms
Hospitalization
Anti-Bacterial Agents
Therapeutics
Neutrophils
Outpatients
Bone Marrow
Psychology
Infection

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Approach to treatment of the febrile cancer patient with low-risk neutropenia. / Buchanan, G. R.

In: Hematology/Oncology Clinics of North America, Vol. 7, No. 5, 1993, p. 919-935.

Research output: Contribution to journalArticle

@article{adc9acfdfe914357a53f341022a5a8ed,
title = "Approach to treatment of the febrile cancer patient with low-risk neutropenia",
abstract = "All cancer patients who develop fever during a period of neutropenia are not at high risk of developing serious infection. Following hospitalization for empiric broad spectrum antibiotic therapy, certain low-risk patients can be identified and safely be discharged 'early', prior to recovery of the absolute neutrophil count to 500 cells per mm3. The medical, psychological, and financial benefits of early hospital discharge are immense. Careful examination for serial increases in components of the peripheral blood count herald marrow recovery and help identify the low risk patient. It may also be possible to identify 'low-risk' neutropenic patients upon development of fever in order to explore alternative management strategies (for example, outpatient oral or intravenous antibiotics) rather than routine hospitalization.",
author = "Buchanan, {G. R.}",
year = "1993",
language = "English (US)",
volume = "7",
pages = "919--935",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Approach to treatment of the febrile cancer patient with low-risk neutropenia

AU - Buchanan, G. R.

PY - 1993

Y1 - 1993

N2 - All cancer patients who develop fever during a period of neutropenia are not at high risk of developing serious infection. Following hospitalization for empiric broad spectrum antibiotic therapy, certain low-risk patients can be identified and safely be discharged 'early', prior to recovery of the absolute neutrophil count to 500 cells per mm3. The medical, psychological, and financial benefits of early hospital discharge are immense. Careful examination for serial increases in components of the peripheral blood count herald marrow recovery and help identify the low risk patient. It may also be possible to identify 'low-risk' neutropenic patients upon development of fever in order to explore alternative management strategies (for example, outpatient oral or intravenous antibiotics) rather than routine hospitalization.

AB - All cancer patients who develop fever during a period of neutropenia are not at high risk of developing serious infection. Following hospitalization for empiric broad spectrum antibiotic therapy, certain low-risk patients can be identified and safely be discharged 'early', prior to recovery of the absolute neutrophil count to 500 cells per mm3. The medical, psychological, and financial benefits of early hospital discharge are immense. Careful examination for serial increases in components of the peripheral blood count herald marrow recovery and help identify the low risk patient. It may also be possible to identify 'low-risk' neutropenic patients upon development of fever in order to explore alternative management strategies (for example, outpatient oral or intravenous antibiotics) rather than routine hospitalization.

UR - http://www.scopus.com/inward/record.url?scp=0027482244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027482244&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 919

EP - 935

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 5

ER -